gallbladder disease |
Disease ID | 600 |
---|---|
Disease | gallbladder disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:10) HP:0001081 | Gallstones | 2 HP:0001513 | Obesity | 1 HP:0001297 | Cerebral vascular events | 1 HP:0001537 | Umbilical hernias | 1 HP:0003077 | Hyperlipidemia | 1 HP:0002758 | Osteoarthritis | 1 HP:0001082 | Cholecystitis | 1 HP:0002664 | Neoplasia | 1 HP:0100790 | Hernia | 1 HP:0009725 | Bladder neoplasm | 1 |
Disease ID | 600 |
---|---|
Disease | gallbladder disease |
Manually Symptom | UMLS | Name(Total Manually Symptoms:4) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:13) | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
2 | 162916413 | rs10490422 | G | T | rs10490422 | pha001404 | 5.92E-18 | phs000007 | phs000342 | 0.09 | [0.07-0.11] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs10490422-C | NA | G | DPP4 | intron |
2 | 198032683 | rs6725302 | A | G | rs6725302 | pha001404 | 1.73E-15 | phs000007 | phs000342 | 0.09 | [0.07-0.11] unit decrease | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs6725302-T | NA | G | ANKRD44 | intron |
3 | 180691092 | rs1010471 | G | A | rs1010471 | pha001403 | 8.11E-05 | phs000007 | phs000342 | -3.941(FBAT) | [NR] | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs1010471-T | NA | A | FXR1 | intron |
5 | 178028356 | rs7717346 | T | C | rs7717346 | pha001404 | 6.47E-15 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs7717346-T | NA | T | NA | NA |
7 | 39747905 | rs10486804 | G | A | rs10486804 | pha001404 | 1.37E-15 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs10486804-G | NA | G | NA | NA |
9 | 20308166 | rs7851959 | G | C | rs7851959 | pha001404 | 1.25E-15 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs7851959-G | NA | G | NA | NA |
10 | 35165095 | rs11010007 | G | A | rs11010007 | pha001404 | 9.75E-15 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit decrease | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs11010007-T | NA | G | NA | NA |
11 | 98596131 | rs3858427 | C | T | rs3858427 | pha001404 | 6.02E-15 | phs000007 | phs000342 | 0.12 | [0.09-0.15] unit decrease | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs3858427-T | NA | C | NA | NA |
11 | 131854850 | rs585904 | T | G | rs585904 | pha001404 | 4.57E-16 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs585904-C | NA | C | NTM | intron |
13 | 96860923 | rs10492589 | A | T | rs10492589 | pha001404 | 1.22E-14 | phs000007 | phs000342 | 0.09 | [0.07-0.11] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs10492589-T | NA | T | HS6ST3 | intron |
13 | 103978779 | rs3918334 | T | G | rs3918334 | pha001403 | 4.76E-05 | phs000007 | phs000342 | -4.067(FBAT) | [NR] | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs3918334-C | NA | T | NA | NA |
20 | 41003185 | rs1015385 | C | A | rs1015385 | pha001403 | 1.50E-05 | phs000007 | phs000342 | 4.328(FBAT) | [NR] | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs1015385-C | NA | A | PTPRT | intron |
21 | 18814425 | rs1389158 | A | G | rs1389158 | pha001404 | 6.34E-17 | phs000007 | phs000342 | 0.11 | [0.08-0.14] unit increase | NA | ALL(0) | ALL(0) | Gallbladder disease | HPOID:0012438 | Abnormal gallbladder physiology | DOID:0000000 | gallbladder disease | NA | NA | NA | NA | Gallbladder disease | rs1389158-T | NA | A | C21orf37 | intron |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:6) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0016977 | s-adenosylmethionine | D012436 | 29908-03-0 | gallbladder diseases | MESH:D005705 | therapeutic | 18518811 | ||
C0016977 | colchicine | D003078 | 64-86-8 | gallbladder diseases | MESH:D005705 | marker/mechanism | 3733464 | ||
C0016977 | lanreotide | C060347 | 118992-92-0 | gallbladder diseases | MESH:D005705 | marker/mechanism | 10601961 | ||
C0016977 | octreotide | D015282 | 83150-76-9 | gallbladder diseases | MESH:D005705 | marker/mechanism | 10601961 | ||
C0016977 | progesterone | D011374 | 57-83-0 | gallbladder diseases | MESH:D005705 | marker/mechanism | 16034922 | ||
C0016977 | streptozocin | D013311 | 18883-66-4 | gallbladder diseases | MESH:D005705 | marker/mechanism | 15384252 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |